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Pluripotent stem cells may serve as an alternative source of beta-like cells for replacement therapy of type 1
diabetes; however, the beta-like cells generated in many differentiation protocols are immature. The maturation
of endogenous beta cells involves an increase in insulin expression starting in late gestation and a gradual
acquisition of the abilities to sense glucose and secrete insulin by week 2 after birth in mice; however, what
molecules regulate these maturation processes are incompletely known. In this study, we aim to identify small
molecules that affect immature beta cells. A cell-based assay, using pancreatic beta-like cells derived from
murine embryonic stem (ES) cells harboring a transgene containing an insulin 1-promoter driven enhanced
green fluorescent protein reporter, was used to screen a compound library (NIH Clinical Collection-003). Cor-
tisone, a glucocorticoid, was among five positive hit compounds. Quantitative reverse transcription–polymerase
chain reaction analysis revealed that glucocorticoids enhance the gene expression of not only insulin 1 but also
glucose transporter-2 (Glut2; Slc2a2) and glucokinase (Gck), two molecules important for glucose sensing.
Mifepristone, a pharmacological inhibitor of glucocorticoid receptor (GR) signaling, reduced the effects of
glucocorticoids on Glut2 and Gck expression. The effects of glucocorticoids on ES-derived cells were further
validated in immature primary islets. Isolated islets from 1-week-old mice had an increased Glut2 and Gck
expression in response to a 4-day treatment of exogenous hydrocortisone in vitro. Gene deletion of GR in beta
cells using rat insulin 2 promoter-driven Cre crossed with GRflox/flox mice resulted in a reduced gene expression
of Glut2, but not Gck, and an abrogation of insulin secretion when islets were incubated in 0.5mM d-glucose
and stimulated by 17mM d-glucose in vitro. These results demonstrate that glucocorticoids positively regulate
glucose sensors in immature murine beta-like cells.
Keywords: small molecule screening, immature beta cells, murine embryonic stem cells, glucose sensors,
postnatal young islets
Introduction
Pancreatic beta cells are required for maintainingglucose homeostasis by secreting insulin when they en-
counter high concentrations of glucose in blood after feeding.
Glucose-stimulated insulin secretion is not observed im-
mediately at birth. Rather, beta cells undergo gradual mat-
uration processes, including an increase of beta cell mass
and insulin expression in beta cells starting at late gestation
[1,2] and the development of glucose-responsive insulin
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secretion comparable to that of their adult counterparts by 2
weeks after birth in mice [3]. Immature islets are character-
ized by a lower responsive threshold to glucose (*2.8mM)
[3], compared with adult islets (5–7mM) [4].
The maturation of beta cells can be controlled by tran-
scription factors in a cell-autonomous manner; for example,
by the transcription factor v-maf musculoaponeurotic fi-
brosarcoma oncogene homolog A (MafA) [5]. MafA is
capable of binding directly to the insulin promoter and en-
hancing insulin gene expression [6]. Knockout of MafA in
the pancreas of mice does not affect the architecture of islets
[7], which contain beta cells at the core and glucagon-
secreting alpha cells at the periphery. The beta-to-alpha cell
ratio is not affected by deletion of MafA either [7]. How-
ever, MafA-knockout mice progressively become diabetic
due to lowered expression of glucose transporter-2 (Glut2)
[7]. Overexpression of MafA delivered by an adeno-viral
vector in cultured islets from 2-day-old rats enhances glu-
cokinase (Gck) expression and glucose-stimulated insulin
secretion [8]. Glut2 [9] and Gck [10] are two key glucose
sensors in beta cells. These studies demonstrate that MafA is
critically important for beta cell maturation. However, little
is known about the noncell autonomous molecules that
regulate beta cell maturation.
Recent studies have demonstrated that insulin-expressing
beta-like cells can be efficiently generated from human
pluripotent stem cells in vitro [11,12]. However, those beta-
like cells do not match their adult counterparts in glucose-
stimulated insulin secretion [11]. In this study, we began to
explore whether immature beta cells can be affected by
small molecules. We reasoned that the practicality of a small
molecule, compared to a transcription factor, would provide
an advantage in delivery to cells to affect the maturation
process in vitro.
We started our investigation by performing a cell-based
screen of a library containing 440 compounds that are
presently on the market or have undergone Phase 1 clinical
trial. A murine embryonic stem (ES) cell line (designated
MIP-EGFP) [13], which contains a transgene with an en-
hanced green fluorescent protein (EGFP) reporter driven by
the murine insulin 1 promoter, was used as the cellular
platform. An increase in fluorescent signal indicates an in-
crease in activity of insulin 1 promoter. Surprisingly, we
found that cortisone, an agonist of the glucocorticoid re-
ceptor (GR; encoded by Nr3c1), caused an increase in the
EGFP signal in the primary screen.
GR is a transcription factor that belongs to a large family of
nuclear hormone receptors and plays multiple roles in de-
velopment, immune response, andmetabolism [14]. In adults,
administration of GR agonists inhibits insulin secretion from
beta cells and causes insulin resistance in peripheral tissues
[15]. During mouse development, inactivation of GR in
pancreatic progenitor cells leads to increased beta cell mass,
suggesting that GR inhibits the differentiation of early pan-
creatic progenitors into beta cells [16]. However, deletion of
GR in the committed beta cells in themouse embryos does not
change beta cell mass or beta-to-alpha cell ratio [16,17],
demonstrating a minimal effect of GR in the differentiated
beta cells. However, whether GR affects maturation of beta
cells has not been determined.
Interestingly, during secondary analyses of the hit com-
pounds we observed that cortisone enhanced expression not
only of Insulin 1 but also of Glut2 and Gck. We therefore
hypothesized that glucocorticoid signaling positively affects
glucose sensors in immature beta cells. In this study, we
show that glucocorticoids increase the gene expression of
Glut2 and Gck in murine ES cell-derived cells, as well as in
immature 1-week-old islets from mice. Genetic knockout of
GR in insulin-expressing beta cells of 1-week-old islets re-
duced Glut2 gene expression and abrogated glucose-
responsive insulin secretion in vitro. These results suggest a
previously unknown role of glucocorticoid signaling in
glucose sensing in immature murine pancreatic beta cells. In
this study, murine cells were used as a model system be-
cause of our extensive experiences in differentiation of
murine ES cells into pancreatic-like cells in vitro [18–21], as
well as the availability of plentiful reagents and transgenic
models in mice. Since many signaling pathways that control
embryonic and postnatal development are commonly shared
among mice and humans, we anticipate that the glucose-
sensing molecules of beta-like cells derived from human
pluripotent stem cells are likely to be affected by gluco-
corticoids as well.
Materials and Methods
Murine ES cell lines
The MIP-EGFP ES cell line (in C57Bl/6 background) was
derived as reported [13] and used in the chemical screening
experiments. The Ngn3-EGFP ES cell line (in 129 back-
ground) contains an EGFP reporter gene driven by the en-
dogenous Neurogenin (Ngn) 3 promoter [22]. MIP-EGFP,
Ngn3-EGFP, and the nontransgenic R1 (in 129 background)
[23] ES cell lines were used for secondary analyses. These
ES cell lines were routinely checked for mycoplasma con-
tamination.
Cell-based screening of compounds
Murine ES cells were differentiated into embryoid bodies
(EBs) in suspension culture for 6 days followed by plating
into two-dimensional attachment culture (in six-well plates)
to generate beta-like cells as reported [18–20] (Supple-
mentary Fig. S1; Supplementary Data are available online at
www.liebertpub.com/scd). For screening experiments, day-6
EBs were plated into flat-bottom, black-walled, 96-well
plates (Corning Costar, Tewksbury, MA; cat. no. 3603) at a
density of 10 EBs per well and incubated at 37C for an
additional 12 days (to yield day-18 cells). Based on our prior
results [18], day 16 was the preferred stage of cells for
starting the screening experiment; however, day-18 cells
were used because of scheduling issues. A total of 440
compounds from the NIH Clinical Collection (NCC-003)
(Supplementary Table S1) were prepared as 10mM stock
solutions in dimethyl sulfoxide (DMSO). Using a Biomek
FX liquid handler (Beckman Coulter, Brea, CA), com-
pounds were diluted 1:100 in water, and subsequently 2 mL
of each of the diluted solutions was added to day-18 cells for
an overall 1:10,000 dilution (the final concentration of each
compound was 1mM). The plates were returned to the in-
cubator for 9 days, with the media supplemented with the
test compounds refreshed every 3 days. DMSO was used as
the vehicle control (n = 8 per experiment). A total of two
screening experiments, each done in technical duplicate,
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were conducted. After 9 days, plates were scanned on an
ImageXpressUltra (MolecularDevices, Sunnyvale,CA) equip-
ped with a 488 nm argon laser to detect the EGFP signal.
The green fluorescence levels were recorded and subse-
quently analyzed using a custom threshold from the Me-
taXpress software (Molecular Devices). The top 1% hits
were selected for subsequent analyses.
Quantitative reverse transcription–polymerase
chain reaction
These methods were the same as previously reported [18].
The internal control used in all experiments was b-Actin.
TaqMan probes used in this study are listed in Supple-
mentary Table S2.
Mice
Both sexes of postnatal CD-1 [24] and C57Bl/6J mice
were used in the experiments associated with Figure 6. A
total of 12–16 young mice were obtained for each experi-
ment. Beta cell-specific GR knockout mice (both sexes)
were generated by mating homozygous GRflox/flox ( Jax mice
stock no. 021021) [25] with rat insulin 2 promoter (RIP)-
driven Cre+/- mice ( Jax mice stock no. 003573) [26].
Breeding was conducted by the Animal Resource Center of
the City of Hope. Genotyping was performed by tail sam-
pling 2–3 days before dissection. Eight-day-old GR b-cell-
KO mice (GRflox/flox; RIP-Cre+/-) and control littermates
(GRflox/flox; RIP-Cre-/-) (both sexes; 4–8 mice per group per
experiment) were used for the studies associated with Fig-
ure 7. All mice were maintained under specific pathogen-
free conditions, and animal experiments were conducted
using protocols approved by the Institutional Animal Care
and Use Committee at City of Hope.
Isolation of one-week-old islets
Mice were routinely euthanized at *10 a.m. Pancreases
were dissected, minced for 2–3min with spring scissors, and
incubated in Dulbecco’s phosphate buffered saline (Corning
Cellgro) containing 1.5mg/mL Collagenase B (Roche Applied
Science, Penzberg, Germany) at 37C for 6–8min with gentle
pipetting after the first 3min. The lightly digested tissue was
washed twice with Hank’s balanced salt solution (HBSS;
Corning Cellgro) containing 0.5% bovine serum albumin
(BSA; Sigma-Aldrich, St. Louis, MO) and resuspended in
Histopaque 1100 (Sigma-Aldrich). An equal volume of HBSS/
0.5% BSAwas carefully layered on top. Density centrifugation
was performed using a Sorvall ST 40r bench top centrifuge
(Thermo Fisher Scientific, Waltham, MA) at 1,400 rpm for
25min at 4C, with the brakes turned off. Islets, in the resulting
middle phase, were carefully collected by a Pasteur pipette. The
islet-enriched fractionwaswashed twicewithHBSS/0.5%BSA
and allowed to recover overnight in 60mm dish in RPMI 1640
supplemented with 10% fetal calf serum (FCS; Tissue Culture
Biologicals, Long Beach, CA) and 11mM d-glucose before
subsequent culture with hydrocortisone (HC) or glucose chal-
lenge in vitro.
Isolation of adult islets
Islets from adult mice (2–4 month old) were isolated as
described [27].
Briefly, pancreases were distended by injecting a solu-
tion containing 2.5mg/mL Collagenase V (Sigma-Aldrich)
through the common bile duct, dissected and digested at
37C for*9min. Following digestion, islets were separated
from the nonislet tissue using Histopaque 1077 (Sigma-
Aldrich). Adult islets were further purified by hand picking
under the visualization of a light microscope.
Culture of islets
Enriched islets were randomly aliquoted (three wells per
group) in 24-well plate and incubated in a medium con-
taining Dulbecco’s modified Eagle’s medium (glucose free;
Corning Cellgro), 15% Knockout Serum Replacement (In-
vitrogen, Carlsbad, CA), 5.0mM d-glucose (Corning Cell-
gro), and 100mg/mL aECM-lam [28] at 37C for 1 or
4 days, in the presence of HC or DMSO control.
In vitro glucose-stimulated C-peptide secretion
Islets were randomly aliquoted (three wells per group) in
96-well plate and incubated at 37C for 2 h in Krebs-Ringer
buffered solution (KRBS; 129mM NaCl, 4.8mM KCl,
2.5mM CaCl2, 1.2mM KH2PO4, 1.2mM MgSO4, 5mM
NaHCO3, 10mM HEPES, and 0.1% BSA) containing 10%
FCS and 0.5mM d-glucose. Subsequently, islets were wa-
shed twice with KRBS containing 2% FCS and 0.5mM
d-glucose and sequentially incubated with 0.5 and 17.0mM
d-glucose (37C, 0.15mL/well, 1.5 h), starting with islets
from GR b-cell-KO followed by control mice. The con-
centration of the released C-peptide in the buffer was
measured using the murine C-peptide ELISA Kit, U-Type
(Shibayaji Co., Gunma, Japan), which has a detection limit
of 30 pg/mL. Stimulation was expressed as the fold change
of C-peptide concentration in buffer from the second (high
glucose) treatment compared with the first (low glucose)
treatment of the same well.
Cortisone, analogs, and other compounds
All small molecules used in this report were purchased
from Sigma-Aldrich and dissolved in DMSO to 10mM
stock concentration before use.
Immunohistochemical staining
The methods were the same as previously reported [29].
Formalin-fixed, paraffin-embedded cells from murine ES
cell-derived cells or postnatal pancreas were processed for
sections and staining. To ensure the specificity of the primary
antibodies, positive control and negative control tissues were
tested first. Subsequently, isotype control antibodies or
omission of the primary antibodies were used in parallel to
the primary antibodies in each staining experiment. Anti-
bodies used are listed in Supplementary Table S3.
Western blot analysis
Cells were lysed on ice in RIPA buffer (Thermo Fisher
Scientific) containing 50mM TRIS, pH 7.4, 150mM NaCl,
0.1mM ethylenediaminetetraacetic acid, 1% Triton X-100,
0.5% sodium deoxycholate, and 0.1% sodium dodecyl sul-
fate (SDS) and supplemented with phosphatase inhibitor
cocktail III (Calbiochem/Merck, Bad Soden, Germany) and
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complete protease inhibitor (Roche, Mannheim, Germany).
Extracts were sedimented at 10,000 g for 15min at 4C to
remove insoluble material. Protein concentrations were de-
termined using the Pierce BCA protein assay (Thermo
Fisher Scientific). Samples (10 mg) of proteins were boiled
in 2· sample buffer (Bio-Rad, Hercules, CA), separated by
SDS-polyacrylamide gel electrophoresis on a 10% Laemmli
gel, transferred to a polyvinylidene difluoride membrane
(Bio-Rad), incubated with primary and secondary anti-
bodies, and developed using enhanced luminol chemilumi-
nescence (ECL Kit; Bio-Rad). Images were detected using
the luminescent image analyzer SERIES 2000A Processor
(TI-BA Enterprises, Rochester, NY). Antibodies used are
listed in Supplementary Table S4.
Statistical analysis
Significance was determined by GraphPad Prism 7 soft-
ware using one-way analysis of variance followed by
Dunnett’s multiple comparison test when three or more
groups were compared or t-tests (unpaired, two-tailed) when
two groups were compared. p< 0.05 was considered sig-
nificant.
Results
Cell-based assay for screening of small
molecules that enhance expression
of the insulin1-EGFP reporter
Our laboratory previously established an in vitro differ-
entiation system to drive murine ES cells into beta-like cells
[18–20]. In those studies, overexpression of MafA between
days 16 and 25 using an inducible murine ES cell line re-
sulted in cells with enhanced expression of Insulin 1, Glut2,
and Gck and increased glucose-stimulated insulin secretion
[18]. These results indicated that cells in this time window
were capable of undergoing maturation and were suitable
targets for the chemical screen used in this study.
MIP-EGFP ES cells were differentiated into EBs, seeded
in 96-well plates, and grown into day-18 cells (Supple-
mentary Fig. S1). Small molecules from the NIH Clinical
Collection-003 were added at a final concentration of 1mM
(n = 2 wells per molecule), and cells were cultured for an
additional 9 days. Negative control wells (n= 8) received the
vehicle DMSO (0.01%). EGFP fluorescence intensity was
recorded at the end of the culture. A hit rate of 1% was
preselected for our screening [30]. Results showed that the
top 1% compounds from our screening had an average
EGFP intensity that was at least 4.57-fold higher than the
DMSO controls (Fig. 1A).
Secondary analyses using commercially-available com-
pounds confirmed that all five hits enhanced the expression
of Insulin 1 in MIP-EGFP ES cells (Fig. 1B), consistent with
the Insulin1-EGFP reporter results (Fig. 1A). The highest
(80-fold) increase of Insulin 1, compared to DMSO control,
was induced by Idarubicin (Fig. 1B). Interestingly, in the
primary screen the green fluorescence signal induced by
Idarubicin was very high (*2,600-fold above the control)
(Fig. 1A). Idarubicin belongs to the family of anthracycline
drugs that are known to emit green fluorescence [31]. In-
deed, under a fluorescence microscope we observed green
fluorescence emission for Idarubicin solution in the absence
of cells (not shown), suggesting that the autofluorescence of
Idarubicin contributes to the strong fluorescence signal.
Among the hits, only cortisone enhanced both Glut2 and
Gck expression compared to controls (Fig. 1B). The effects
of cortisone on Glut2 and Gck were confirmed in four in-
dependent experiments (Fig. 1C). To determine if the effects
of cortisone were cell line specific, we tested murine Ngn3-
EGFP ES cells [19], which have a genetic background
different from that of MIP-EGFP cells. Cortisone also en-
hanced Glut2 and Gck expression in Ngn3-EGFP ES cells
(Fig. 2A). Together, these results identified cortisone as a
promising subject for further study.
Other glucocorticoids also enhance Glut2 and Gck
expression in murine ES cell-derived cells
In addition to cortisone, we tested the effects of three other
glucocorticoids-hydrocortisone (HC), dexamethasone (Dex),
and prednisolone (Pred) (Fig. 3A). Expression of both Glut2
andGckwas increased by all three compounds inMIP-EGFPES
cell-derived cells (Fig. 3A), demonstrating that these effects are
not unique to cortisone. Similarly in Ngn3-EGFP ES cells, HC,
Dex, and Pred increased expression ofGlut2 andGck (Fig. 2B),
showing again that the effects are not cell line specific. Because
HC (also known as cortisol) is the natural glucocorticoid hor-
mone secreted by the adrenal gland, this compound, rather than
cortisone, was selected for subsequent studies.
Pharmacological inhibition of GR signaling reduces
HC-induced Glut2 and Gck expression in murine
ES-derived cells
To test whether HC enhances expression of Glut2 and
Gck through GR signaling in day-18 cells, mifepristone
[32], a GR antagonist, was added at increasing concentra-
tions to cells cultured in 1mM HC for 9 days (Fig. 3B). A
dose-dependent inhibition of Glut2 and Gck by mifepristone
was observed (Fig. 3B), suggesting that the effects of HC
were dependent on GR signaling.
Protein expression of GLUT2 is enhanced by HC
in murine ES-derived cells
Time course analyses demonstrated that expression of
Glut2 and Gck was elevated in MIP-EGFP ES-derived cells
after 6 days of HC treatment (Fig. 4A); therefore, this time
point was used for subsequent analyses. Glut2 expression
was confirmed by western blot analysis and found to be
enhanced by HC after 6 days of treatment in MIP-EGFP ES-
derived cells (Fig. 3C).
Hepatocytes are known to express Glut2 [33]. To ensure
that Glut2 is expressed by beta-like cells derived from
murine ES cells, we performed double immunostaining of
C-PEPTIDE (a marker for de novo synthesized insulin) and
Glut2 (Fig. 3D). R1 murine ES cells were used in these
experiments because this cell line does not carry an EGFP
transgene. Time course analysis in R1 ES cells confirmed
that expression of Glut2 and Gck was enhanced in the
presence of HC after 6 days (Fig. 4B). In addition, GR
protein was detected in the C-peptide positive cells in day-
18 cultures (Fig. 5), confirming that murine ES-derived cells
are equipped to respond to glucocorticoids. GLUT2 became
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detectable in C-PEPTIDE expressing cells treated with 1 mM
HC for 6 days, but not in those treated with the DMSO
control (Fig. 3D). These results confirm that HC increases
the expression of GLUT2 in beta-like cells derived from
murine ES cells in vitro.
Beta cells of young mice express lower levels of GR
and Glut2 and show different patterns of protein
localization compared with adult beta cells
To further validate the findings from the murine ES cell
system, we studied primary islets of young mice. Double
immunostaining of formalin-fixed, paraffin-embedded pan-
creatic tissues confirmed the presence of GR proteins in beta
cells of postnatal day (P)3, P8, and adult mice (Fig. 6A).
Interestingly, GR was localized mostly in the cytoplasm at
P3, both cytoplasm and nucleus at P8, and mostly nucleus in
the adult beta cells. GR messages were detected in isolated
islets from P5, P8, and adult mice, with higher levels of GR
in adult compared with P5 and P8 islets (Fig. 6B). In this
study, P5 islets instead of P3 islets were isolated because P3
islets were difficult to separate cleanly from the acinar tis-
sues (not shown). The significance of the differential ex-
pression and localization of GR in young versus adult islets
FIG. 1. Screening of the NIH
Clinical Collection (NCC-003)
leads to the identification of five hit
compounds that increase Insulin 1
expression in mES cell-derived
pancreatic-like cells. (A) In the
primary screening, the top five
compounds showed more than
fourfold increases in insulin1-
EGFP reporter signals, compared to
DMSO controls. (B) Secondary
analyses, using MIP-EGFP mES-
derived cells and commercially-
available compounds, confirmed
the increased expression of Insulin
1. Other genes, including Insulin 2,
Glut2, and Gck, were examined as
well. Day-18 cells (in six-well
plates) derived from murine MIP-
EGFP ES cells were cultured in the
presence of designated compounds
for 9 days and gene expression
analyzed by qRT-PCR using b-
Actin as the internal control. Data
represent fold change compared to
the DMSO vehicle control (desig-
nated as ‘‘0’’). Note that cortisone
(but not the other compounds) en-
hanced the expression of both
Glut2 and Gck. Data represent
mean – SD of three independent
experiments. Significance was de-
termined by one-way ANOVA
analysis. (C) Summary of the ef-
fects of cortisone on Glut2 and Gck
expression. Data represent mean –
SD of four independent experi-
ments. Significance was deter-
mined by t-test. *, **, ***, and
**** indicate P< 0.05, P< 0.01,
P < 0.001, and P < 0.0001, respec-
tively, compared to the DMSO
control. mES, murine embryonic
stem; EGFP, enhanced green fluo-
rescent protein; DMSO, dimethyl
sulfoxide; qRT-PCR, quantitative
reverse transcription–polymerase
chain reaction; SD, standard devi-
ation; ANOVA, analysis of vari-
ance; GR, glucocorticoid receptor;
Glut2, glucose transporter-2; Gck,
glucokinase.
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is presently unknown, but may suggest a stage-specific
function of GR in beta cells.
It has been previously shown that Glut2 messages are
increased in adult islets compared with those in the postnatal
young mice [34,35]; here we confirmed this finding showing
higher gene expression of Glut2 in adult compared to P5 and
P8 islets (Fig. 6B). Double immunostaining of GLUT2 and
insulin revealed that, in the P3 and P8 beta cells, GLUT2 was
found mostly in the cytoplasm, with a subpopulation dis-
playing higher intensity of GLUT2 on the plasma membrane
(Fig. 6A). In contrast, GLUT2 localized mostly on cell sur-
face of the adult beta cells (Fig. 6A). These results are con-
sistent to prior reports on GLUT2 [34–37] and suggest that a
lower Glut2 gene expression and a protein localization at the
cytoplasm are associated with beta cell immaturity.
HC enhances gene expression of Glut2 and Gck
in postnatal young islets in vitro
The results above (Fig. 6A) demonstrate that primary
young beta cells are equipped with GR to respond to HC. To
further test this, islets were isolated from 1-week-old mice
using density centrifugation, allowed to recover overnight
and cultured in the presence of HC or vehicle for 1 or 4 days
(Fig. 6C). Expression of Glut2 and Gck was significantly
increased by day 4 in islets treated with HC compared to
vehicle (Fig. 6C), demonstrating that primary immature beta
cells respond to glucocorticoids by increasing Glut2 and
Gck gene expression.
Genetic knockout of GR in beta cells
of one-week-old mice results in a reduced Glut2
but not Gck gene expression
To further test whether the expression of Glut2 and Gck re-
quires GR in endogenous beta cells of 1-week-old mice, we
deleted the GR gene in insulin-expressing cells by crossing
GRflox/flox mice [38] with rat insulin 2 promoter (RIP)-Cre+/-
[26] mice (Supplementary Fig. S2). One-week-old GRflox/flox;
RIP-Cre+/- (GR b-cell-KO) mice appeared normal, consis-
tent to prior reports [16,17]. Islets and acinar cells (Sup-
plementary Fig. S3) were isolated from pancreases of
1-week-old GR b-cell-KO mice and GRflox/flox;RIP-Cre-/-
littermates (controls), allowed to recover overnight and an-
alyzed by quantitative reverse transcription–polymerase
chain reaction. Expression of GR was reduced but not absent
from the islet cell preparation in GR b-cell-KO mice,
compared to controls (Fig. 7A). In GRflox/flox mice [25],
exon 3 of GR, which contains the DNA-binding domain, is
flanked by the loxP sequences and deleted in the GR b-cell-
KO mice. The TaqMan probes that we used recognize GR at
the junction of exons 2 and 3. Therefore, the GR mRNAs
detected in the islet preparation of GR b-cell-KO mice were
most likely due to the presence of other endocrine cells and
the potential contamination of some acinar cells. Expression
of Glut2, but not Gck, was decreased in the GR knockout
islets compared to the controls (Fig. 7A), suggesting that GR
is required for Glut2 but not Gck expression in primary
young islets. The significance of the lack of Gck reduction in
the absence of GR is not clear but may be due to a com-
pensatory effect by other nuclear receptors [39].
GR is required for insulin secretion by young islets
incubated in 0.5mM and stimulated with 17mM
d-glucose in vitro
Finally, to test whether the islets of GR b-cell-KO mice
were functional, isolated islets were subjected to sequential
incubations with low (0.5mM) and high (17.0mM) con-
centrations of d-glucose in vitro. The concentration of
0.5mM d-glucose was used because, as mentioned, young
beta cells have a lower glucose threshold (*2.8mM) for
stimulation compared with adult beta cells [3]. The amount
of C-PEPTIDE released to the buffer was determined by
enzyme linked immunosorbent assay. The stimulation index
FIG. 2. Effects of cortisone and other glucocorticoids on
Glut2 and Gck gene expression in Ngn3-EGFP mES-derived
cells. Day-18 cells derived from the Ngn3-EGFP mES cells
were incubated with cortisone (A) or three other gluco-
corticoids (B) for a total of 9 days. The resulting cells were
analyzed by qRT-PCR using b-Actin as the internal control.
Data represent fold change compared to the DMSO vehicle
control (designated as ‘‘0’’). Data represent mean – SD of
three independent experiments. Significance was determined
by one-way ANOVA. *, **, ***, and **** indicate P < 0.05,
P < 0.01, P < 0.001, and P < 0.0001, respectively, compared
to the DMSO control. Ngn, neurogenin.
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(ie, the ratio of concentrations of C-PEPTIDE in the me-
dium measured at high and low concentrations of d-glucose)
was determined. Control young islets exhibited a positive
response to glucose as shown by a stimulation index of *2
(Fig. 7B). In contrast, islets from GR b-cell-KO mice did
not secrete C-PEPTIDE in response to high concentrations
of glucose, as indicated by a stimulation index near 1. These
results demonstrate that GR is required for the postnatal
young beta cells to secrete insulin in response to high con-
centrations of d-glucose in vitro.
Discussion
A rise in glucocorticoid concentrations in plasma during
late gestation in multiple species [40] and between postnatal
days 5 and 15 in mice [41] has led to the hypothesis that
glucocorticoid signaling is important for the maturation of
organs critical for survival after birth. Indeed, glucocorticoid
signaling affects the maturation of several organs and cell
types [40]. For example, glucocorticoids enhance the mat-
uration of perinatal lung epithelium by promoting the ex-
pression of surfactant [42], induce myofibril assembly and
systolic function of fetal heart [43], and increase amylase
expression and secretion in pancreatic acinar cells in post-
natal young rats [44].
In this study, we have discovered that beta cell maturation
is also positively affected by glucocorticoid signaling.
Specifically, exogenous HC is sufficient to increase gene
expression of Glut2 and Gck, two molecules critical for
glucose sensing, both in ES-derived beta-like cells and
primary young islets. In addition, we found that genetic
deletion of GR in the 1-week-old beta cells reduced Glut2
but not Gck expression, demonstrating that GR is critically
important for Glut2 expression in young beta cells.
FIG. 3. Glucocorticoids
enhance expression of Glut2
and Gck in mES cell-derived
beta-like cells through GR
signaling. Day-18 cells de-
rived from mES cells were
cultured in the presence of
designated glucocorticoids for
9 (A, B) or 6 (C, D) days. (A)
qRT-PCR analyses showed
that glucocorticoids enhanced
the expression of Glut2 and
Gck in MIP-EGFP mES-
derived cells. b-Actin was
used as the internal control.
Data represent fold change
compared to the DMSO ve-
hicle control (designated as
‘‘0’’). Data represent mean–
SD of three independent ex-
periments. Significance was
determined by one-way AN-
OVA. *, **, ***, and ****
indicate P< 0.05, P< 0.01,
P< 0.001, and P< 0.0001, re-
spectively, compared to the
DMSO control. (B) Mifepris-
tone, a GR antagonist, in-
hibited the effects of HC on
the expression of Glut2 and
Gck. Data represent mean–
SD of three independent ex-
periments. Significance was
determined by one-way
ANOVA.* and** indicate P<
0.05 and P<0.01, respectively.
(C) Western blot analysis
showed that protein expression
of Glut2 was enhanced by HC.
b-ACTIN was the loading con-
trol. (D) Double immunofluo-
rescence staining showed that
C-PEPTIDE expressing cells
coexpressed GLUT2 after HC
treatment of R1 mES-derived
cells. Scale bar=50mm. HC,
hydrocortisone; Dex, dexa-
methasone; Pred, prednisolone.
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FIG. 4. Time course analyses on
the effects of HC onGlut2 andGck
expression. Day-18 cells from (A)
MIP-EGFP or (B) R1 mES cells
received 1 or 10 mM HC or DMSO
control for 3, 6, or 9 days. The re-
sulting cells were analyzed by
qRT-PCR using b-Actin as the in-
ternal control. Six days of HC
treatment, compared to the DMSO
control, were sufficient to induce
higher expression of Glut2 and
Gck in both ES cell lines. There-
fore, in some subsequent experi-
ments we used an endpoint of
6 days post-HC incubation. Data
represent mean – SD of three
independent experiments. Sig-
nificance was determined by one-
way ANOVA. * indicates P < 0.05
compared to the DMSO control.
FIG. 5. mES-derived pancreatic-
like cells express GR. Day-18 cells
derived from R1 mES cells were
fixed, paraffin-embedded, sectioned,
and stained with rabbit anti-C-
PEPTIDE and mouse anti-GR anti-
bodies. Scale bar= 50mm.
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The increased expression of Glut2 in young islets induced
by exogenous HC was unlikely to be an in vitro artifact
because increases in expression of the Glut2 gene from the
neonate to adult islets are known to occur in vivo [34,35]
and confirmed in this study (Fig. 6B). In addition, we found
1 mM (36mg/100mL) exogenous HC to be sufficient to in-
crease Glut2 and Gck expression by murine ES-derived
beta-like cells and 1-week-old islets; this dose is above
average but within the physiological range among newborn
babies [45]. Taken together, our results demonstrate a
FIG. 6. Postnatal young islets express GR and GLUT2 and respond to HC in enhancingGlut2 andGck expression. (A) Postnatal
day (P) 3, P8, and adult pancreaseswerefixed in formalin, paraffin-embedded, sectioned, and stainedwith insulin andGRantibodies.
Scale bar=50mm. (B) Islets were isolated from P5, P8, and adult mice and gene expression analyzed by qRT-PCR. Data represent
mean–SD from three independent experiments. Significance was determined by one-way ANOVA. **** indicates P< 0.0001
compared to either P5 or P8 islets. (C) P7 islets were isolated and cultured in the presence of HC for 1 or 4 days. At the end of the
culture, gene expression was analyzed by qRT-PCR using b-Actin as internal control. Data represent fold change compared to the
DMSO control (designated as ‘‘0’). Data represent mean–SD of four independent experiments. Significance was determined by
one-way ANOVA. *, **, and *** indicate P<0.05, P<0.01, and P<0.001, respectively, compared to the DMSO control.
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positive role of glucocorticoid signaling in enhancing glu-
cose sensing in immature beta cells. The enhancement of
glucose sensing in immature beta cells, however, may not be
sufficient to induce fully mature insulin secretion, because
secretion requires additional steps, such as opening of ion
channels, membrane depolarization, and exocytosis [46].
Further studies are needed to test the effects of glucocorti-
coids and GR on the later steps of insulin secretion in young
beta cells. In addition, whether glucocorticoid signaling is
sufficient to raise the glucose threshold in young beta cells
to the adult level awaits further investigation.
Our results are surprising in lieu of the extensive literature
demonstrating the inhibitory effects of glucocorticoids on adult
beta cells [15]. The reason as to why glucocorticoid signaling
might elicit different outcomes in young beta cells versus their
adult counterparts is currently unknown, but we note that
mature (but not immature) dendritic cells are susceptible to
apoptotic signals induced by glucocorticoids due to the ex-
pression of different translational isoforms of GR [47].
Glucocorticoid signaling is known to regulate metabolism
in adults [15]. The positive effects of glucocorticoids on im-
mature beta (this study), acinar [44], and liver [40] cells—cell
types important for metabolism, implicate the roles of glu-
cocorticoid signaling in general metabolism of sucklingmice.
We speculate that feeding schedules in suckling mice may
affect glucocorticoid signaling [48,49], which in turn may
affect the peripheral clocks in the pancreas and liver [50] that
regulate the expression of genes controlling metabolism.
We anticipate that GR agonists may enhance the efficacy
of in vitro-generated beta-like cells derived from human
pluripotent stem cells by enabling these cells to better sense
glucose. Human pluripotent stem cell-derived pancreatic pro-
genitor cells [51] are currently being tested (ClinicalTrial.gov;
ID: NCT02239354) for cell replacement therapy in type 1 di-
abetes patients, in whom beta cells are destroyed by autoim-
mune attacks. As mentioned, beta-like cells can now be
efficiently generated fromhuman pluripotent stemcells in vitro
[11,12], but they are relatively immature [11]. Interestingly, in
their in vitro differentiation protocols for human pluripotent
stem cells some laboratories have already used glucocorticoids
to increase insulin-expressing cells [52] and glucose-
stimulated insulin release [53]; however, the mechanisms un-
derlying those results have remained unclear. The current study
provides mechanistic insight into the potential effects of glu-
cocorticoid signaling in immature human beta-like cells.
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